World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
29595
World Ranking
16474
National Ranking
8280

Overview

Bruce A. C. Cree is affiliated with the University of California, San Francisco in the United States. Their research is primarily situated within the field of Medicine, with a significant focus on subfields including Pathology and Forensic Medicine, Neurology, Immunology, Molecular Biology, and Oncology.

Their work extensively covers several main topics related to neurology and immunology, particularly:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Immunotherapy and Immune Responses
  • Polyomavirus and related diseases
  • Sphingolipid Metabolism and Signaling
  • Systemic Sclerosis and Related Diseases
  • T-cell and B-cell Immunology

Bruce A. C. Cree has contributed to an array of recent scientific publications, including:

  • "Treatment of Multiple Sclerosis: A Review," 2020, The American Journal of Medicine
  • "Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course," 2022, Cell
  • "Secondary Progressive Multiple Sclerosis," 2021, Neurology
  • "Gut microbiota-specific IgA + B cells traffic to the CNS in active multiple sclerosis," 2020, Science Immunology
  • "Locus for severity implicates CNS resilience in progression of multiple sclerosis," 2023, Nature

The frequent collaborators in Bruce A. C. Cree's research include:

  • Amit Bar-Or
  • Stephen L. Hauser
  • Hans-Peter Hartung
  • Jeffrey M. Gelfand
  • Douglas L. Arnold

Research publications by Bruce A. C. Cree often appear in well-established journals such as:

  • Neurology
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Annals of Neurology
  • Neurology Neuroimmunology & Neuroinflammation

The breadth of Bruce A. C. Cree's work spans studies that delve into the pathology of multiple sclerosis and related neurological conditions, with frequent examination of the immune system's role in disease mechanisms. Their integration of molecular biology approaches supports investigations into immune responses within the central nervous system.

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Risk alleles for multiple sclerosis identified by a genomewide study.

    David A. Hafler;Alastair Compston;Stephen Sawcer;Mark J. Daly

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.

    Egle Cekanaviciute;Bryan B. Yoo;Tessel F. Runia;Justine W. Debelius

  • Treatment of Multiple Sclerosis: A Review

    Stephen L. Hauser;Bruce A.C. Cree

  • An open label study of the effects of rituximab in neuromyelitis optica

    B. A.C. Cree;S. Lamb;K. Morgan;A. Chen

  • Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.

    Anu Jacob;Brian G Weinshenker;Ivo Violich;Nancy McLinskey

  • Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

    Sergio E. Baranzini;Joanne Wang;Rachel A. Gibson;Nicholas Galwey

  • Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

    Ari J Green;Jeffrey M Gelfand;Bruce A Cree;Carolyn Bevan

  • Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

    Bruce A C Cree;Jeffrey L Bennett;Ho Jin Kim;Brian G Weinshenker

  • Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

    Alexander Rae-Grant;Gregory S. Day;Ruth Ann Marrie;Alejandro Rabinstein

  • Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

    Fred Lublin;David H Miller;Mark S Freedman;Bruce A C Cree

  • Silent progression in disease activity-free relapsing multiple sclerosis.

    Bruce A C Cree;Jill A Hollenbach;Riley Bove

  • Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans

    Jorge R. Oksenberg;Lisa F. Barcellos;Bruce A.C. Cree;Sergio E. Baranzini

  • Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis

    Lisa F. Barcellos;Lisa F. Barcellos;Lisa F. Barcellos;Stephen Sawcer;Patricia P. Ramsay;Sergio E. Baranzini

  • Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter

    Michel Varrin-Doyer;Collin M. Spencer;Ulf Schulze-Topphoff;Patricia A. Nelson

  • Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.

    Ulf Schulze-Topphoff;Michel Varrin-Doyer;Kara Pekarek;Collin M. Spencer

  • Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis

    B. A.C. Cree;O. Khan;D. Bourdette;D. S. Goodin

  • Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis:

    Ludwig Kappos;Nicola De Stefano;Mark S. Freedman;Bruce A. C. C. Cree

  • A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility.

    David Reich;David Reich;Nick Patterson;Philip L De Jager;Philip L De Jager;Philip L De Jager;Gavin J McDonald;Gavin J McDonald

Frequent Co-Authors

Stephen L. Hauser
Stephen L. Hauser University of California, San Francisco
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Sergio E. Baranzini
Sergio E. Baranzini University of California, San Francisco
Jorge R. Oksenberg
Jorge R. Oksenberg University of California, San Francisco
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Roland G. Henry
Roland G. Henry University of California, San Francisco
Patrick Vermersch
Patrick Vermersch University of Lille

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean following the traditional, lengthy educational route. Many students and professionals are seeking flexible, accelerated options that can jumpstart their medical careers or open doors to advanced opportunities. For example, if you're already a registered nurse, a 1 year dnp program online can help you achieve the highest level of nursing practice in a short time frame.

Those looking to enter the healthcare field quickly might consider fast track medical programs, which enable students to fast-forward their journey to becoming a licensed practical nurse. If you're interested in specializing in mental health, you can pursue an msn to pmhnp online program, paving the way to a rewarding advanced practice role.

Not all healthcare careers are patient-facing; many roles are available in administration and management. Earning one of the health administration degrees online can launch you into leadership positions within hospitals, clinics, and health organizations. Online options make it easier than ever to balance your studies with your personal and professional commitments.

Best Scientists Citing Bruce A. C. Cree

Trending Scientists

Recently Published Articles